| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.898938 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107174959 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 210420e20220210onc ob f000 0 eng d |
|---|
| 020 | |a9780660385310 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH139-24/2021E-PDF |
|---|
| 245 | 00|aGood manufacturing practices for active pharmaceutical ingredients. |
|---|
| 246 | 17|aGood manufacturing practices for active pharmaceutical ingredients, version 2 (GUI-0104) |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cFebruary 10, 2022. |
|---|
| 264 | 4|c©2021 |
|---|
| 300 | |a1 online resource (127 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Bonnes pratiques de fabrication des ingrédients pharmaceutiques actifs. |
|---|
| 500 | |a"GUI-0104." |
|---|
| 500 | |a"Pub.: 210054." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references (pages 116-119). |
|---|
| 650 | 0|aDrugs|xStandards|zCanada. |
|---|
| 650 | 0|aDrug factories|zCanada. |
|---|
| 650 | 0|aPharmaceutical industry|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tBonnes pratiques de fabrication des ingrédients pharmaceutiques actifs.|w(CaOODSP)9.898940 |
|---|
| 856 | 40|qPDF|s2.19 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H139-24-2021-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/guidelines-active-pharmaceutical-ingredients-0104/document.html |
|---|